H.R. 2276 (112th): To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Introduced:

Jun 22, 2011
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on June 22, 2011, in a previous session of Congress, but was not enacted.

Sponsor:

Debbie Wasserman Schultz
Representative for Florida's 20th congressional district
Democrat

Text:

Read Text »
Last Updated: Jun 22, 2011
Length: 3 pages

About the bill

Summary (CRS)
6/22/2011--Introduced.Directs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) to: (1) study ways to provide independent, confirming genetic diagnostic test ...

Read more >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 1249 (Related)
Leahy-Smith America Invents Act

Enacted — Signed by the President
Sep 16, 2011

What is a bill?

The “H.R.” in “H.R. 2276” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
Jun 22, 2011

Details

Cosponsors
none
Committee Assignments
Health

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: